Antiviral Therapy Recommendations for Mollaret Meningitis

Acute Episode Management

• Supportive care (analgesia and intravenous fluids as needed) is the only recommended treatment for an acute Mollaret meningitis episode; antiviral agents provide no benefit. 1
• High‑quality evidence shows that oral aciclovir or valaciclovir does not improve outcomes in HSV‑ or VZV‑associated meningitis. 1, 2
• Drug‑related adverse events (e.g., nephrotoxicity in up to 20 % of patients) and unnecessary prolongation of hospital stay outweigh any theoretical antiviral advantage. 1, 3
• Empiric antibiotics should be discontinued promptly once a viral etiology is confirmed by cerebrospinal fluid (CSF) PCR. 1
• After virologic confirmation, discharge planning should be expedited to avoid unnecessary hospitalization. 1

Prophylactic Antiviral Therapy

• Prophylactic antiviral therapy is not recommended for preventing recurrence of HSV‑2 Mollaret meningitis; this recommendation is based on Level I evidence. 1
• In a placebo‑controlled trial, oral valaciclovir failed to reduce recurrence rates of HSV‑2 meningitis. 1, 2, 4
• Participants receiving valaciclovir actually exhibited a trend toward higher relapse rates after the trial ended. 1, 2
• The lack of efficacy is attributed to insufficient drug concentrations in the CSF; aciclovir levels were not directly measured in the study. 1, 4
• No clinical trials have evaluated higher‑dose antiviral regimens for this indication. 1, 4

Diagnostic Confirmation

• CSF PCR targeting HSV‑2 is the gold‑standard test for confirming viral etiology in suspected Mollaret meningitis. 1
• Routine laboratory panels typically include testing for enterovirus, HSV‑1, HSV‑2, and VZV. 1
• In 30‑50 % of patients with clinically presumed viral meningitis, no causative pathogen is identified. 1

Critical Exception – Encephalitis

• If any encephalitic features develop, immediate initiation of intravenous aciclovir (10 mg/kg three times daily for 14–21 days) is mandated for presumed HSV encephalitis, per the British Infection Association/Association of British Neurologists guidelines. 3
• Encephalitic features requiring urgent treatment include:
  
  • New personality, behavioral, or cognitive changes – 1
  • Altered level of consciousness – 1, 2
  • Reduced Glasgow Coma Scale score – 3

Clinical Pitfalls to Avoid

• Do not mistake Mollaret meningitis for encephalitis; patients usually retain normal consciousness, and any mental status change suggests an alternative diagnosis. 1, 2
• Do not prescribe prophylactic antivirals for recurrent meningitis, even though they are effective for reducing genital HSV‑2 transmission and recurrences. 1, 2
• Do not assume a concurrent genital herpes history; most individuals with HSV‑2‑related Mollaret meningitis have no documented genital ulcers. 2

Prognosis

• Complete recovery between meningitis episodes is the norm. 1
• Episodes may be separated by intervals ranging from several months to years. 1, 2

Mollaret Meningitis: Evidence‑Based Guidelines

Definition

• Mollaret meningitis (benign recurrent lymphocytic meningitis) is a rare syndrome marked by recurrent aseptic meningitis episodes with complete recovery between attacks and symptom‑free intervals that may last from days to years【5】.

Etiology

• Herpes simplex virus type 2 (HSV‑2) is the predominant causative pathogen, identified in the majority of cases where a virus is isolated【5】.
• Other, less common viral agents include HSV‑1, varicella‑zoster virus, cytomegalovirus, Epstein–Barr virus, and mumps virus【5】.

Clinical Presentation

• Patients typically present with sudden‑onset meningismus—headache, neck stiffness, and photophobia—although fever may be absent【5】.
• Most individuals do not have concurrent genital ulcers or a known history of genital herpes【5】.
• Altered consciousness is generally absent; its presence should prompt evaluation for alternative diagnoses such as encephalitis【5】.
• Symptom‑free intervals between attacks can vary widely, ranging from a few days to several years【5】.

Diagnostic Work‑up

• CSF PCR for HSV‑2 is the gold‑standard test to confirm viral etiology; a clinical diagnosis can be made after exclusion of other causes of recurrent lymphocytic meningitis【5】【6】.
• Routine CSF PCR panels should include testing for enteroviruses, HSV‑1, HSV‑2, and VZV【5】.
• Blood cultures are recommended to rule out bacterial meningitis【7】.

CSF Findings

• The presence of classic “Mollaret cells” (large endothelial‑type cells with indistinct cytoplasm) is considered a hallmark, although they are rarely observed in contemporary practice【5】.

Management

Acute Episode

• Primary therapy is supportive—adequate analgesia and intravenous fluids—while awaiting diagnostic confirmation【5】【8】.
• Some clinicians administer aciclovir or valaciclovir during an acute episode, but current evidence does not demonstrate a clear benefit (low‑quality evidence)【5】【8】.
• Antibiotics should be discontinued once a viral etiology is established【5】.

Prophylaxis

• Placebo‑controlled trials have shown that oral valaciclovir does not reduce recurrence of HSV‑2 meningitis and may increase relapse rates after discontinuation (Level I evidence)【5】【8】.
• The UK Joint Specialist Societies explicitly advise against routine aciclovir/valaciclovir prophylaxis for recurrent herpes meningitis【5】.

Emergency Consideration

• If encephalitic features develop (e.g., personality change, altered consciousness), immediate treatment with intravenous aciclovir for presumed HSV encephalitis is recommended【5】【8】.

Prognosis

• Complete recovery between episodes is the norm, and long‑term outcomes are excellent, with a spontaneous decline in recurrence frequency over time【5】.